Zimbabwe has declined a significant American healthcare agreement worth 367 million US dollars (272 million pounds) over five years due to Washington's insistence on sensitive information.
The decision was revealed after a internal memorandum dated December was disclosed, indicating that President Emmerson Mnangagwa deemed the agreement was "skewed".
An official spokesperson has since clarified that the US was requesting health data for scientific study and commercial purposes but refused to share the benefits from any future medical innovations.
"We must now begin the challenging and unfortunate process of ending our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had provided more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has urged more negotiations to reach a agreement acceptable to all parties so the nation's critical HIV programme can be sustained.
Wider Context
This development comes after a comparable case in Kenya, where a high court suspended a similar deal with the US after legal challenges were filed about the safety of citizens' health data.
Since returning to office recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
USAID had overseen aid for the American government, but Trump argued its expenditure was "inefficient" and his government was pursuing government-to-government deals to boost transparency and accountability.
According to reports, Sixteen African countries have so far agreed to similar health pacts, representing over $18.3bn of fresh investment.
Details of the Rejected Agreement
This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation could have provided extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via American-funded programmes," the Ambassador added.
However, official spokesman Nick Mangwana said the arrangement was "unequal".
"Zimbabwe was being asked to share its biological resources and data for a long time, without any equivalent promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could result from that provided information," he stated.
"In essence, our nation would provide the basic resources for medical research with no assurance that the end products would be available to our population if a future disease outbreak emerge."
National Interest and Global Health
Mangwana further noted that the American exit from the global health body and its push of one-on-one health agreements were upending systems already established via the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing system created to deal with future pandemics.
"This mechanism is intended to guarantee that when a nation provides its information, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised solely by those with the resources to create them."
The government's concerns over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We welcome further discussions with our US partners on how subsequent collaboration could be designed in a manner that honours the independence and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the official position, but recommended that negotiations should continue since much of the nation's Aids initiatives relied on external financing.
"If technical issues arise, including those relating to data governance or implementation frameworks, these can frequently be addressed via detailed discussion and mutually agreed protections," the group added.
The situation emphasises the continuing tensions between receiving vital foreign assistance and protecting local interests in an increasingly interconnected world.